Healthcare & Life Sciences

FDA Response Letter for Docket FDA-2026-P-0529

The FDA has posted a response letter related to docket FDA-2026-P-0529. The document was authored by the Center for Veterinary Medicine (CVM) and is available for download. No other details or specific actions are indicated.

FDA Proposed Collection for Animal Drug User Fees

The Food and Drug Administration (FDA) has published a proposed collection of information regarding animal drug and animal generic drug user fees. This notice initiates a public comment period for the proposed reporting requirements associated with these user fees.

FDA National Priority Voucher Pilot Program Public Hearing Request

The FDA is announcing a public hearing regarding its National Priority Voucher Pilot Program. The hearing will be held on June 12, 2026, and is intended to gather public input on the program. Registration details and requests for participation are available on the FDA website.

FDA Seeks Comment on Advisory Committee Information Collection

The Food and Drug Administration (FDA) is requesting public comment on its proposed collection of information related to advisory committee activities. This notice initiates a comment period for stakeholders to provide feedback on the agency's information collection requests concerning these committees.

NCVHS Charter Renewal Notice

The Centers for Disease Control and Prevention (CDC) has published a notice regarding the renewal of the charter for the National Committee on Vital Health and Statistics (NCVHS). This notice serves to inform the public about the continuation of the committee's operations.

South Carolina Measles Outbreak Update

The South Carolina Department of Public Health reported no new measles cases since Tuesday, maintaining the Upstate outbreak total at 997. The update also provided demographic and vaccination status breakdowns of the cases. The department continues to emphasize vaccination as the primary prevention method.

Kansas Air Quality Health Advisory for Prescribed Burns

The Kansas Department of Health and Environment (KDHE) has issued an air quality health advisory for central and eastern Kansas due to smoke from prescribed burns in the Flint Hills. Elevated air pollutant levels, including particulate matter and ozone, are expected from March 20-21, 2026, potentially impacting air quality to 'Unhealthy for Sensitive Groups' or 'Unhealthy' levels.

Texas Medical Board Enforcement Update and CE Tracking

The Texas Medical Board has updated its enforcement approach, introducing warning letters and letters of concern as less punitive tools for administrative and isolated violations. This change aims to streamline enforcement and reduce compliance burdens for licensees while maintaining accountability and patient safety.

Alabama Public Health: Protecting Kids from Adult Products

The Alabama Department of Public Health (ADPH) and the Alabama Poison Information Center (APIC) have issued guidance on protecting children from common adult products like essential oils and caffeinated beverages. The guidance highlights the dangers of accidental ingestion and provides emergency contact information.

Missouri Identifies Two Residents with Clade I Mpox

The Missouri Department of Health and Senior Services announced the identification of two adult residents with clade I mpox, a more severe strain of the virus. These are the first known cases of clade I mpox in Missouri and the thirteenth and fourteenth nationally, linked to recent international travel.

Nurse Disciplinary Order: Permanent Voluntary Surrender

The Maryland Board of Nursing has accepted the permanent voluntary surrender of Imafidon Akhigbe's multistate licensure privilege to practice as a Licensed Practical Nurse. This action follows findings that Akhigbe's LPN school was withdrawn from approval and that Akhigbe provided false information on her licensure application regarding clinical training.

Maryland Board of Nursing Consent Order of Reprimand for Imafidon Akhigbe

The Maryland Board of Nursing issued a Consent Order of Reprimand against Imafidon Akhigbe, a Medication Technician. The order stems from alleged violations of the Maryland Nurse Practice Act related to her LPN application and attendance at an LPN school. The reprimand addresses her Medication Technician certificate.

Maryland Rural Health, Workforce, and Agriculture Funding Discussion

Maryland state agencies and partners met to discuss the potential impact of $168 million in federal funding for the Rural Health Transformation Program. The funding aims to strengthen rural health care, bolster the workforce, and support the agriculture industry in Maryland's Eastern Shore counties.

Measles Exposure Locations Identified in Salem

Oregon Health Authority and Marion County public health officials have identified two new measles exposure locations in Salem, Oregon. They are urging individuals who may have been exposed at Salem Health Hospital or Kaiser Permanente Skyline Medical Office between March 13 and March 16, 2026, to contact their healthcare provider.

New Mexico Measles Cases Rise to 13

The New Mexico Department of Health has reported that measles cases have increased to 13, with all cases linked to three county detention centers. Vaccination crews have been deployed to these facilities to prevent further spread. The state is also encouraging residents to check their vaccination records due to ongoing measles activity.

Swissmedic: Lisdexamfetamine Contraindication for Pheochromocytoma Patients

Swissmedic is updating the contraindications for lisdexamfetamine dimesylate to include patients with pheochromocytoma. This change aims to prevent potentially life-threatening increases in catecholamine levels. The product information for both healthcare professionals and patients will be amended to reflect this new contraindication.

WHO Guidance on Responsible AI in Mental Health

The WHO has released guidance based on expert recommendations for the responsible use of AI in mental health. The guidance emphasizes recognizing generative AI use as a public mental health concern, integrating mental health into AI impact assessments, and co-designing AI tools with experts and individuals with lived experience.

Medicaid Fraud Control Units Annual Report: FY 2025

The HHS OIG has released its annual report for Medicaid Fraud Control Units (MFCUs) for Fiscal Year 2025. The report details nearly $2 billion in combined criminal and civil recoveries, 1,185 convictions, and 900 exclusions from federal health care programs. It highlights trends in fraud and patient abuse investigations and prosecutions.

Philips Radiology Device Safety Alert

The French ANSM has been informed of a safety action initiated by Philips Medical Systems Nederland BV concerning radiology devices. Affected users have received a direct communication from the company regarding this action, registered under ANSM reference R2606927.

ANSM Safety Alert: Eonis SCID-SMA Kit for Genetic Testing

The French ANSM has issued a safety alert regarding the Eonis SCID-SMA kit for genetic testing, manufactured by Wallac/Revvity. Affected users have been notified directly by the company, and the alert is registered under ANSM reference R2607970.

South Dakota Department of Health Updates Fish Consumption Advisory

The South Dakota Department of Health has updated its fish consumption advisory list to include Lake Louise for Largemouth Bass, based on recent sampling data. This update provides consumers with current information to make informed decisions about eating locally caught fish.

FDA Seeks Comment on Priority Voucher Pilot Program

The FDA has published a Federal Register Notice seeking public comment on its Commissioner's National Priority Voucher pilot program. The agency also announced a public hearing on June 12, 2026, to gather stakeholder feedback on various aspects of the program's implementation and effectiveness.

Wisconsin Pharmacy Board Rule Changes

The Wisconsin Pharmacy Examining Board has updated Chapter Phar 7, concerning the Practice of Pharmacy, with changes effective January 1, 2021. These updates were adopted on June 4, 2020, and provide important information for licensees regarding pharmacy practice regulations.

Wisconsin Pharmacy Board Updates and Rule Changes

The Wisconsin Pharmacy Examining Board issued a newsletter on September 17, 2020, providing updates on rule changes, COVID-19 variances, and enforcement actions. A key update concerns changes to administrative rules in Chapter Phar 7, effective January 1, 2021.

Wisconsin Pharmacy Board Rule Updates and Enforcement Actions

The Wisconsin Pharmacy Examining Board has updated administrative rules effective August 1, 2020, affecting rule chapters Phar 6 (Storage) and Phar 17 (Internships). These updates include adoption orders outlining specific changes to storage requirements and internship regulations for licensed pharmacists and interns in Wisconsin.

Wisconsin Pharmacy Board Activities: PDMP, HOPE, Opioid Treatment

The Wisconsin Pharmacy Board is providing an update on its activities, including the implementation of the Prescription Drug Monitoring Program (PDMP), participation in the Heroin, Opiate Prevention and Education (HOPE) legislation, and significant rewrites of Chapters 7 (Pharmacy Practice) and 15 (Sterile Pharmaceuticals) of its rules. The PDMP has seen substantial provider registration and inquiry volume, aiming to curb controlled substance abuse.

DEA Virtual Assembly on Fentanyl Risks

The DEA Omaha Division is promoting a free virtual assembly on fentanyl and fake pill risks for middle and high school educators. The event is scheduled for April 7, 2026, and aims to educate attendees on the dangers associated with these substances.

DEA Technical Amendment for Ordering Schedule I and II Controlled Substances

The DEA issued a technical amendment to clarify regulations regarding the execution and revocation of Powers of Attorney for DEA Form 222, used for ordering Schedule I and II controlled substances. This amendment corrects administrative errors to align with previous policy decisions, ensuring clarity on who can sign these forms and removing obsolete transition provisions.

DEA Notice of Application for Controlled Substance Import Registration

The Drug Enforcement Administration (DEA) has published a notice regarding an application from Siegfried Grafton, Inc. to be registered as an importer of specific controlled substances, including Gamma Hydroxybutyric Acid and Marihuana. Registered bulk manufacturers and other applicants may submit comments or requests for a hearing by April 20, 2026.

DEA Seizes 4.7M Fentanyl Pills and 2,396 lbs Powder

The DEA announced the seizure of over 4.7 million fentanyl pills and nearly 2,396 pounds of fentanyl powder during Phase 2 of Operation Fentanyl Free America. This operation removed over 57 million deadly doses of fentanyl from communities across the United States.

DEA Miami Combats Illicit Vape and Edible Products

The DEA Miami and Tampa Field Divisions are actively combating illicit vape and edible products containing dangerous controlled substances. This initiative highlights ongoing enforcement efforts to protect community members from these harmful products.

Massachusetts Pharmacist Medication Administration Guidance Update

The Massachusetts Department of Public Health issued a circular letter updating guidance on pharmacist medication administration. This update authorizes pharmacists to administer testosterone for gender-affirming care, and medications for the prevention and treatment of HIV and sexually transmitted infections, in addition to existing authorizations for mental illness and substance use disorder treatments.

Massachusetts Pharmacist Administration of Medications Guidance

The Massachusetts Department of Public Health issued guidance allowing pharmacists and pharmacy interns to administer additional medications, including testosterone for gender-affirming care, and treatments for HIV and STIs. This guidance replaces a previous version and provides details on eligibility and administration requirements.

Center for Scientific Review Notice of Closed Meetings

The National Institutes of Health, through the Center for Scientific Review, has published a notice announcing upcoming closed meetings. These meetings are scheduled for April 16, 2026, and involve discussions that are not open to the public.

ACF Seeks Public Comment on Native Americans Program Policies

The Administration for Native Americans (ANA) is seeking public comment on its program policies and procedures. This notice provides an opportunity for stakeholders to provide input on how ANA operates its programs, which are designed to serve Native American communities.

NIH Center for Scientific Review Closed Meetings Notice

The National Institutes of Health (NIH) has published a notice regarding upcoming closed meetings for the Center for Scientific Review. These meetings are scheduled for April 16, 2026, and are part of the standard operational procedures for reviewing grant applications.

NIH Government Inventions Available for Licensing

The National Institutes of Health (NIH) has published a notice announcing the availability of government-owned inventions for licensing. This notice provides information for parties interested in obtaining licenses for these inventions.

National Human Genome Research Institute Meeting Notice

The National Institutes of Health (NIH) published a notice announcing an upcoming meeting for the National Human Genome Research Institute. The meeting is scheduled to take place on May 18-19, 2026. This notice serves as an informational announcement regarding the meeting details.

FDA Variance Amendment from Whisky A Go Go

The Food and Drug Administration (FDA) has posted a variance amendment related to "Whisky A Go Go." The document is available for review on regulations.gov, though no specific details or downloadable content are provided directly in the listing.

FDA CDRH Variance Approval Letter to Smack Shack

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Smack Shack. This document grants a specific variance, the details of which are not publicly available in the provided text.

FDA Variance Amendment from Leo Weeks Photographers

The FDA has posted a variance amendment submitted by Leo Weeks Photographers. The document is available for review on Regulations.gov, though no specific details or full text are provided directly in the listing.

FDA CDRH Variance Approval Letter to Furew Floral

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Furew Floral Event and Landscaping. This document signifies an approval for a specific variance requested by the company.

FDA Variance Amendment from Furew Floral Event

The FDA has posted a variance amendment related to the Furew Floral Event and Landscaping. This document, authored by CDRH, is available for review on Regulations.gov. No specific compliance actions or deadlines are detailed in the provided information.

FDA Variance Approval Letter to DJ Ken-E. Ken

The Food and Drug Administration (FDA) has posted a Variance Approval Letter related to DJ Ken-E. Ken. The document was issued by the Center for Devices and Radiological Health (CDRH). No other details or documents are available for viewing.

FDA Variance Application from Jennifer Rishel

The FDA has posted a variance application submitted by Jennifer Rishel. The application, filed by CDRH, is available in redacted format on regulations.gov. No specific details on the nature of the variance or its implications are provided in the posting.

FDA Acknowledgment Letter to Whisky A Go Go

The Food and Drug Administration (FDA) has issued an acknowledgment letter to Whisky A Go Go. The letter, originating from the Center for Devices and Radiological Health (CDRH), confirms receipt of correspondence but provides no further details on its content or implications.

FDA Complaint Posted for Public Comment

The FDA has posted a complaint for public comment, with the comment period closing on March 19, 2026. The document is available on Regulations.gov, though no content is directly viewable, only an attachment labeled 'Complaint' from the author CTP.

FDA Complaint Filed

The FDA has filed a complaint regarding a matter related to its regulatory oversight. The document indicates that comments were closed on March 19, 2026. No specific details about the complaint's nature or the parties involved are available in the provided metadata.

FDA Variance Application - Furew Floral Event and Landscaping

The Food and Drug Administration (FDA) has received a variance application from Furew Floral Event and Landscaping. The application, submitted by CDRH, is available for review on Regs.gov.

FDA Letter to U.S. Patent and Trademark Office

The Food and Drug Administration (FDA) has posted a letter addressed to the U.S. Patent and Trademark Office. The document is available on Regulations.gov and was authored by the Center for Drug Evaluation and Research (CDER).